Scholarlink

Purpose of Review <p>Despite the availability of potent antifungal compounds, invasive fungal diseases (IFD) are still a major cause for morbidity and mortality in immunocompromised pediatric and adult patients, and risk and outcome of IFDs are determined by the degree of the suppression of the specific arms of the immune system. This prompted us to review the current knowledge of immunotherapeutic antifungal approaches.</p> Recent Findings <p>We critically review important in vitro and animal data as well as clinical studies of immunotherapy for IFD, in particular granulocyte transfusion, the adoptive transfer of primary and genetically modified Natural Killer cells and fungal-specific T cells, and the use of colony-stimulating factors and cytokines.</p> Summary <p>Although promising data of in vitro and animal models have been reported for many strategies, no clear benefit has been demonstrated in the clinical setting to date. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immunotherapeutic Approaches to Invasive Fungal Disease in the Immunocompromised Child

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月19日

查看全文
  • Stanislaw Schmidt,
  • Konrad Bochennek,
  • Henriette Rudolph,
  • Thomas Lehrnbecher

摘要

Purpose of Review

Despite the availability of potent antifungal compounds, invasive fungal diseases (IFD) are still a major cause for morbidity and mortality in immunocompromised pediatric and adult patients, and risk and outcome of IFDs are determined by the degree of the suppression of the specific arms of the immune system. This prompted us to review the current knowledge of immunotherapeutic antifungal approaches.

Recent Findings

We critically review important in vitro and animal data as well as clinical studies of immunotherapy for IFD, in particular granulocyte transfusion, the adoptive transfer of primary and genetically modified Natural Killer cells and fungal-specific T cells, and the use of colony-stimulating factors and cytokines.

Summary

Although promising data of in vitro and animal models have been reported for many strategies, no clear benefit has been demonstrated in the clinical setting to date.